GE HealthCare (GEHC): financials, SEC filings and peers

GE HealthCare (GEHC) is a health care equipment company in the Health Care sector of the S&P 500, headquartered in Chicago, Illinois.

It was founded in 1994 and joined the S&P 500 on January 4, 2023.

Its fiscal year ends in December, and its shares trade on the Nasdaq.

In its SEC filings it is classified as “X-Ray Apparatus & Tubes & Related Irradiation Apparatus”.

GE HealthCare at a glance

Revenue (12 months): $21.0B
Revenue growth: +6.0%
Operating margin: 12.6%
Net income (12 months): $1.9B
Free cash flow (12 months): —
Cash: $2.3B
Debt: $10.1B
Diluted EPS (12 months): $4.18

Twelve months to March 31, 2026, from the 10-Q filed April 29, 2026.

Latest twelve months

Over the twelve months to March 31, 2026, GE HealthCare reported revenue of $21.0 billion, about the same as a year earlier (+6.0%).

Its operating margin was 12.6%, down 1.1 percentage points from a year earlier: for every $100 of sales, about $13 was left as operating profit.

Net income was $1.9 billion (9.1% of revenue), 12.5% lower than a year earlier.

Profit fell while sales grew, which usually points to higher costs, heavier investment or one-time items. The filings explain which.

At the end of the period it held $2.3 billion in cash and $10.1 billion in debt, a net debt position of $7.9 billion.

Five-year trend

Revenue went from $17.6 billion in fiscal 2021 to $20.6 billion in fiscal 2025, about 4.1% a year.
Revenue has grown for 4 fiscal years in a row.
Operating margin narrowed from 15.9% to 13.4% over the same years.
Free cash flow was positive in each of the last 5 fiscal years.

Fiscal year	2021	2022	2023	2024	2025
Revenue	$17.6B	$18.3B	$19.6B	$19.7B	$20.6B
Revenue growth	—	4.3%	6.6%	0.6%	4.8%
Operating margin	15.9%	13.8%	12.5%	13.3%	13.4%
Net income	$2.2B	$1.9B	$1.6B	$2.0B	$2.1B
Free cash flow	$1.4B	$1.8B	$1.7B	$1.6B	$1.5B
Diluted EPS	$4.95	$4.22	$3.03	$4.34	$4.55

Fiscal years as reported in GE HealthCare’s 10-K filings. Free cash flow is operating cash flow minus capital spending.

Recent SEC filings

8-K filed September 22, 2026 — Executive or director change; Regulation FD disclosure
8-K filed August 18, 2026 — Executive or director change
8-K filed July 29, 2026 — Regulation FD disclosure
10-Q filed July 29, 2026 — quarterly report
8-K filed July 29, 2026 — Earnings results
8-K filed July 23, 2026 — Earnings results; Executive or director change
8-K filed May 11, 2026 — Shareholder vote results; Other event
10-Q filed April 29, 2026 — quarterly report

All GE HealthCare filings on SEC EDGAR

Companies like GE HealthCare

Other S&P 500 companies in Health Care Equipment:

More from Health Care

All 60 Health Care companies →

Questions about GE HealthCare

Is GE HealthCare's revenue growing?

Yes. Revenue for the twelve months to March 31, 2026 was $21.0 billion, up 6.0% from a year earlier, according to its SEC filings.

Is GE HealthCare profitable?

Yes. It earned $1.9 billion in net income over the twelve months to March 31, 2026, a net margin of 9.1%.

Does GE HealthCare have more cash or more debt?

At March 31, 2026 it had $2.3 billion in cash and $10.1 billion in debt, so more debt than cash.

When did GE HealthCare last file financial results?

Its latest quarterly report (10-Q) was filed with the SEC on July 29, 2026.

Which companies are similar to GE HealthCare?

In the S&P 500, GE HealthCare is grouped in Health Care Equipment within the Health Care sector. Abbott Laboratories (ABT), Baxter International (BAX), Becton Dickinson (BDX), Boston Scientific (BSX), Dexcom (DXCM) are in the same group.

Understand the numbers

Source: GE HealthCare’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved September 27, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.